Alignd

Based in South Africa, Alignd delivers clinical healthcare solutions focused on patient-centered, value-based care, addressing the complexities of the healthcare system through tailored support services. Alignd is a clinical healthcare solutions provider founded in 2018 and headquartered in Cape Town, South Africa. The company was established to enhance patient care and has since completed 1 deal, with its most recent funding round occurring on September 10, 2025. Alignd was founded by individuals dedicated to improving healthcare delivery, although specific details about their backgrounds are not disclosed.

Alignd specializes in providing patient-centered, value-based healthcare solutions designed to address the complexities of the healthcare system. Their core offerings include tailored support services that prioritize the physical, medical, and emotional needs of patients, as well as end-to-end solutions that engage all stakeholders—patients, providers, and funders—in a cohesive manner. Alignd's services are aimed at maximizing patient comfort and ensuring that healthcare resources are utilized effectively. The company serves a diverse client base, including over 3,500 patients who have benefitted from their specialized care, operating primarily within the South African market.

Alignd generates revenue through partnerships with funders, healthcare providers, and direct service offerings to patients. Their business transactions are structured around subscription-based models and collaborative agreements that facilitate tailored care solutions. Clients typically engage with Alignd for integrated healthcare services that may include palliative care and management of complex health needs. This interaction leads to predictable revenue streams, as funders and healthcare schemes support patient access to specialized resources and services.

While specific pricing details for their flagship offerings are not publicly disclosed, the company’s commitment to delivering high-value care ensures that their solutions are effective and economically viable for all stakeholders involved. In September 2025, Alignd secured an investment from E Squared Investments, enabling the company to enhance its offerings in maternity care and kidney disease treatment across healthcare institutions. This funding will support Alignd's expansion into new markets and geographic regions, with specific plans to broaden its reach in the South African healthcare landscape. The investment will facilitate the development of upcoming new products aimed at improving healthcare delivery in these areas.